Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The von Willebrand factor A domain containing 5B pseudogene (ENSG00000258823, LOC100421646) is an unprocessed partial pseudogene located on chromosome 22, homologous to exons 23–34 of the VWF gene[4]. It contains multiple nonsense and splice-site mutations and does not encode a functional protein[2][3]. While the functional von Willebrand factor is a key adhesive glycoprotein in hemostasis, mediating platelet adhesion and acting as a carrier for Factor VIII, the pseudogene does not participate in these processes[4][1]. It should not be confused with the functional gene or protein and is not considered a therapeutic target nor used in clinical assays or as a biomarker[4][2][3]. In summary, von Willebrand factor A domain containing 5B pseudogene is a nonfunctional pseudogene and should not be regarded as a therapeutic target or biologically relevant molecule for drug development or biomarker purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Von Willebrand factor A domain containing 5B pseudogene.